Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Revenue

Rekah Pharmaceutical Industry had revenue of 75.07M ILS in the quarter ending September 30, 2025, a decrease of -13.90%. This brings the company's revenue in the last twelve months to 300.24M, down -9.46% year-over-year. In the year 2024, Rekah Pharmaceutical Industry had annual revenue of 321.71M with 0.02% growth.

• Revenue (ttm): 300.24M
• Revenue Growth: -9.46%
• P/S Ratio: 0.44
• Revenue / Employee: 713.17K
• Employees: 421
• Market Cap: 132.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	321.71M	49.00K	0.02%
Dec 31, 2023	321.66M	29.27M	10.01%
Dec 31, 2022	292.39M	28.44M	10.78%
Dec 31, 2021	263.95M	-1.52M	-0.57%
Dec 31, 2020	265.47M	68.97M	35.10%